SCOTT CURRAN: Open Payments
NPI 1750875787 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 45 payments from 20 companies in 2025. Trend: 2023 $2,075 · 2024 $1,199 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $218 |
| ABBVIE INC. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Impel Pharmaceuticals LLC | 2 | $49 |
| Astellas Pharma US Inc | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| PFIZER INC. | 2 | $36 |
| SANOFI-AVENTIS U.S. LLC | 2 | $31 |
Products named: Ozempic, Saxenda, Kerendia, MOUNJARO, UBRELVY, TRUDHESA, Veozah, Auvelity.
Industry payments across TN — which companies pay providers there.
